ISB News

Big Money, Big Science

America’s most productive biologist on philanthropy’s role in science

Leroy Hood, M.D., Ph.D., is one of America’s most successful and distinguished scientist-inventors. Four devices he created proved instrumental in decoding the human genome. He pioneered the important new field of systems biology, which studies complex biological linkages and uses technology and mathematics to map and explain interrelationships. He has been awarded seven of the highest prizes in experimental science, and a dozen and a half companies have been spun off of his research work. On January 31, 2013 he spoke with Philanthropy magazine in Washington, D.C., about the crucial importance of private giving in making his scientific successes possible.

Philanthropy: You’ve been involved on the for-profit side of biomedical research, and you’ve been involved in the nonprofit side. What do you consider the distinct advantages of working with nonprofit funders when you’re pursuing this research?

Leroy Hood: Why don’t I tell you a little bit about my history, because I’ve seen that question from at least three different vantage points?

I was a faculty member at Caltech for 22 years, starting in 1970, and there my major interests were developing new technologies. Among other things, we developed the automated DNA sequencer that made the human-genome project possible. We also did a good deal of molecular immunology, molecular biology. And I would say, at Caltech, philanthropy played a really catalytic and interesting role in a number of ways. Perhaps the most spectacular was in the development of the automated DNA sequencer itself.

Philanthropy: How so?

Leroy Hood: In the early 1980s when we conceptualized the instrument but were just getting ready to develop it, we put in a number of grants to the National Institutes of Health in Washington. They got some of the worst scores the NIH had ever given. People said what we wanted to do was impossible, or they said, “Why do this? Grad students can do it more easily.”

So what I did was fashion together a really interesting consortium of philanthropy and business. The philanthropy was Sol Price. After making a lot of money he had helped start the Weingart Foundation that he guided for many years. What was terrific about Sol Price was he was really smart and flexible, and excited by innovation and new ideas. Read the interview…

Recent Articles

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.

  • Hack Your Health: An Evening with Anjali Nayar and Dr. Sean Gibbons

    Netflix’s “Hack Your Health: The Secrets of Your Gut” is a documentary that merged gut microbiome experts, four individuals – including a well-known hot dog eating champion – facing personal battles with gastrointestinal health, and a unique, effective visual method of “showing” the gut microbiome in action.